Parallel Advisors
AGIO icon

Parallel Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Parallel Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$665 Hold
20
– – ﹤0.01% 3850
2026
Q2 		$742 Hold
20
– – ﹤0.01% 3737
2026
Q1 		$677 Buy
20
+8
+67% +$227 ﹤0.01% 3613
2025
Q4 		$327 Hold
12
– – ﹤0.01% 3466
2025
Q3 		$482 Hold
12
– – ﹤0.01% 3334
2025
Q2 		$399 Sell
12
-492
-98% -$14.9K ﹤0.01% 3335
2025
Q1 		$14.8K Buy
504
+12
+2% +$398 ﹤0.01% 2281
2024
Q4 		$16.2K Sell
492
-20
-4% -$940 ﹤0.01% 2236
2024
Q3 		$22.7K Buy
512
+20
+4% +$908 ﹤0.01% 2020
2024
Q2 		$21.2K Buy
+492
New +$17.8K ﹤0.01% 1948
2023
Q4 		– Sell
-23
Closed -$569 – 3318
2023
Q3 		$569 Hold
23
– – ﹤0.01% 3082
2023
Q2 		$651 Buy
+23
New +$572 ﹤0.01% 3044
2022
Q4 		– Sell
-4
Closed – – 3347
2022
Q3 		$0 Buy
+4
New +$107 ﹤0.01% 3112
2022
Q1 		– Sell
-9
Closed – – 2931
2021
Q4 		$0 Sell
9
-44
-83% -$1.77K ﹤0.01% 3051
2021
Q3 		$2K Sell
53
-18
-25% -$870 ﹤0.01% 2637
2021
Q2 		$4K Sell
71
-69
-49% -$3.86K ﹤0.01% 2336
2021
Q1 		$7K Buy
140
+38
+37% +$1.88K ﹤0.01% 2045
2020
Q4 		$4K Sell
102
-666
-87% -$26.3K ﹤0.01% 2066
2020
Q3 		$27K Sell
768
-794
-51% -$34.8K ﹤0.01% 1311
2020
Q2 		$83K Buy
1,562
+1,465
+1,510% +$67.8K 0.01% 831
2020
Q1 		$3K Sell
97
-40
-29% -$1.85K ﹤0.01% 2007
2019
Q4 		$7K Buy
137
+106
+342% +$4.01K ﹤0.01% 1839
2019
Q3 		$1K Buy
+31
New +$1.28K ﹤0.01% 2243
2018
Q3 		– Sell
-29
Closed -$2K – 2217
2018
Q2 		$2K Hold
29
– – ﹤0.01% 1808
2018
Q1 		$2K Buy
+29
New +$2.24K ﹤0.01% 1802

Other funds holding AGIO

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

Parallel Advisors's AGIO Position: Q3 2026 in Review

Parallel Advisors held its Agios Pharmaceuticals (AGIO) position steady in Q3 2026 at 20 shares worth $665. The position accounts for ﹤0.01% of the portfolio, ranked #3850.

Parallel Advisors first reported a position in AGIO in Q1 2018 and has held it in 25 quarters since. The position peaked at $83K in Q2 2020. 64 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

  • Parallel Advisors held 20 shares of Agios Pharmaceuticals worth $665 as of Q3 2026.
  • Parallel Advisors left its Agios Pharmaceuticals share count unchanged in Q3 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #3850 holding.
  • Parallel Advisors first reported a position in Agios Pharmaceuticals in Q1 2018 and has held it in 25 quarters since.
  • Parallel Advisors's Agios Pharmaceuticals position peaked at $83K in Q2 2020.
  • 64 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.